World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
146
Citations
69689
World Ranking
1348
National Ranking
785

Joseph H. Antin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joseph H. Antin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 914 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joseph H. Antin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph H. Antin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 146 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1997 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Joseph H. Antin is affiliated with the Dana-Farber Cancer Institute in the United States. Their research primarily focuses on medicine, with extensive contributions to hematology, genetics, immunology, oncology, and public health, environmental and occupational health.

The scientist has a significant body of work within the field of hematopoietic stem cell transplantation. Key research topics also include acute myeloid leukemia research, immune cell function and interaction, acute lymphoblastic leukemia research, polyomavirus and related diseases, myeloproliferative neoplasms diagnosis and treatment, and chronic myeloid leukemia treatments.

Joseph H. Antin has published numerous papers in prominent venues. Frequent publication outlets include:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Journal of Clinical Oncology
  • UNC Libraries

Notable recent papers include:

  • "Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial", 2020, Blood
  • "HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis", 2021, Blood
  • "Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide", 2021, Blood Advances
  • "GVHD Prophylaxis 2020", 2021, Frontiers in Immunology
  • "Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial", 2022, The Lancet Haematology

The scientist collaborates frequently with several coauthors, including:

  • Corey Cutler
  • Robert J. Soiffer
  • Mahasweta Gooptu
  • Vincent T. Ho
  • Sarah Nikiforow

Joseph H. Antin's work encompasses comprehensive studies of hematopoietic cell transplantation strategies, immune reconstitution, and transplant-related complications. Their research contributions address key issues related to donor selection, prophylaxis after transplantation, and outcomes for patients with hematologic conditions.

In recognition of career achievements, Joseph H. Antin was named a Fellow of the American Association for the Advancement of Science (AAAS) in 1997.

Best Publications

  • Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

    R H Collins;O Shpilberg;W R Drobyski;D L Porter

  • Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough

  • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

    John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda

  • Cytokine dysregulation and acute graft-versus-host disease.

    J. H. Antin;J. L. M. Ferrara

  • Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.

    Thomas R. Ziegler;Lorraine S. Young;Kathleen Benfell;Marc Scheltinga

  • Cholecystokinin elicits the complete behavioral sequence of satiety in rats.

    Joseph Antin;James Gibbs;Jonathan Holt;Robert C. Young

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang

  • Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

    Craig Kollman;Craig W. S. Howe;Claudio Anasetti;Joseph H. Antin

  • Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

    Richard A. Nash;Joseph H. Antin;Chatchada Karanes;Joseph W. Fay

  • Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

    R Coleman Lindsley;Wael Saber;Brenton G Mar;Robert Redd

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.

    David L. Porter;Mark S. Roth;Carol McGarigle;James Ferrara

  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

    Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  • Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

    Jason A. Coppell;Paul G. Richardson;Robert Soiffer;Paul L. Martin

  • Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

    Stephanie J. Lee;John P. Klein;A. John Barrett;Olle Ringden

  • Contribution of bone marrow-derived endothelial cells to human tumor vasculature

    Brock A Peters;Luis A Diaz;Kornelia Polyak;Leslie Meszler

  • Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

    Ann M. Leen;Catherine M. Bollard;Adam M. Mendizabal;Elizabeth J. Shpall

  • Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis

    Corey Cutler;Satyendra Giri;Suriya Jeyapalan;David Paniagua

Frequent Co-Authors

Robert J. Soiffer
Robert J. Soiffer Harvard University
Corey Cutler
Corey Cutler Harvard University
Vincent T. Ho
Vincent T. Ho Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
Jerome Ritz
Jerome Ritz Harvard University
John Koreth
John Koreth Harvard University
Haesook T. Kim
Haesook T. Kim Harvard University
Philippe Armand
Philippe Armand Harvard University
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of medicine in the USA offers many alternative career pathways and online degree options for those seeking flexibility and growth. If you are interested in healthcare roles that don’t require medical school, there are accessible options to consider. For example, medical coding and billing classes online with financial aid can provide entry into vital administrative positions in healthcare, often with minimal prerequisites.

Aspiring nurses may benefit from programs tailored for easy entry. Some lpn school without teas test requirements allow you to get started quickly, bypassing standardized entrance exams.

Those looking to move into healthcare management roles should explore options like accelerated healthcare administration degree online programs. These can prepare you for leadership positions in hospitals and clinics more efficiently.

Nurses wanting to advance their education might consider specialized bridge programs such as asn to np programs, which help registered nurses rapidly earn advanced practitioner qualifications.

Together, these flexible and affordable online options open doors for non-traditional students and those seeking career advancement in healthcare.

Best Scientists Citing Joseph H. Antin

Trending Scientists

Recently Published Articles